Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 15, 2005 - Issue 5
Submit an article Journal homepage
31
Views
5
CrossRef citations to date
0
Altmetric
Review

New insights into the development of ATP-sensitive potassium channel openers

Bernard PirotteNatural and Synthetic Drugs Research Center Laboratoire de Chimie Pharmaceutique, Université de Liège, 1, Avenue de l’Hôpital, B-4000 LiègeBelgiumTel: +32 4 366 43 65; Fax: +32 4 366 43 62; E-mail: [email protected]
,
Pascal de TullioLaboratoire de Pharmacodynamie et de Thérapeutique Université Libre de Bruxelles, 808, route de Lennik, B-1070, BruxellesBelgium
,
Marie-Hélène AntoineNatural and Synthetic Drugs Research Center Laboratoire de Chimie Pharmaceutique, Université de Liège, 1, Avenue de l’Hôpital, B-4000 LiègeBelgiumTel: +32 4 366 43 65; Fax: +32 4 366 43 62; E-mail: [email protected]
,
Sophie SebilleLaboratoire de Pharmacodynamie et de Thérapeutique Université Libre de Bruxelles, 808, route de Lennik, B-1070, BruxellesBelgium
,
Xavier FlorenceNatural and Synthetic Drugs Research Center Laboratoire de Chimie Pharmaceutique, Université de Liège, 1, Avenue de l’Hôpital, B-4000 LiègeBelgiumTel: +32 4 366 43 65; Fax: +32 4 366 43 62; E-mail: [email protected]
&
Philippe LebrunLaboratoire de Pharmacodynamie et de Thérapeutique Université Libre de Bruxelles, 808, route de Lennik, B-1070, BruxellesBelgium
Pages 497-504 | Published online: 10 May 2005

Bibliography

  • NOMA A: ATP-regulated K+ channels in cardiac muscle. Nature (1983) 305:147–148.
  • COOK DL, HALES CN: Intracellular ATP directly blocks K+ channels in pancreatic B cells. Nature (1984) 311:271–273.
  • ALLARD B, LAZDUNSKI M: Pharmacological properties of ATP-sensitive K+ channels in mammalian skeletal muscles cells. Eur. J. Pharmacol. (1993) 236:419–426.
  • STANDEN NB, QUAYLE JM, DAVIES NW, BRAYDEN JE, HUANG Y, NELSON MT: Hyperpolarizing vasodilators activate ATP-sensitive IQ-channels in arterial smooth muscle. Science (1989) 245:177–180.
  • QUAYLE JM, NELSON MT, STANDEN NB: ATP-sensitive and inwardly rectifying potassium channels in smooth muscle. PhysioL Rev. (1997) 77:1165–1232.
  • BERNARDI HA, FOSSET M, LAZDUNSKI M: Purification and affinity labeling of a brain PH-glibenclamide binding protein, a putative neuronal ATP-regulated IQ-channel. Proc. Nati Acad. Sci. USA. (1988) 85:9816–9820.
  • ASHCROFT FM: Adenosine 5'-triphosphate-sensitive potassium channels. Ann. Rev. Neurosci. (1988) 11:97–118.
  • PETERSEN OH, DUNNE MJ: Regulation of IQ- channels plays a crucial role in the control of insulin secretion. Pflügers Arch. (1989) 414:S115–S120.
  • KOLB HA: Potassium channels in excitable and non-excitable cells. Rev. Physiol Biochem. Pharmacol (1990) 15:51–79.
  • AMOROSO S, SCHMID-ANTOMARCHI H, FOSSET M, LAZDUNSKI M: Glucose, sulfonylureas, and neurotransmitter release: role of ATP-sensitive K* channels. Science (1990) 247:852–854.
  • NICHOLS CG, LEDERER WJ: The regulation of ATP-sensitive IQ channel activity in intact and permeabilized rat ventricular myocytes. J. Physiol (1990) 423:91–110.
  • GASSER RN, VAUGHAN-JONES RD: Mechanism of potassium efflux and action potential shortening during ischaemia in isolated mammalian cardiac muscle. Physiol. (1990) 431:713–741.
  • LIU Y, SATO T, O'ROURKE B, MARBAN E: Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation (1998) 97:2463–2469.
  • INAGAKI N, GONOI T, CLEMENT JP et al: Reconstitution of IKATp: an inward rectifier subunit plus the sulfonylurea receptor. Science (1995) 270:1166–1170.
  • BABENKO AP, AGUILAR-BRYAN L, BRYAN J: A view of SUR/Kir6.X KATp channels. Ann. Rev. PhysioL (1998) 60:667–687.
  • ISOMOTO S, KONDO C, YAIVIADA M et al: A novel sulfonylurea receptor forms with BIR (Kir6.2) a smooth muscle type ATP-sensitive K* channel. J. Biol. Chem. (1996) 271:24321–24324.
  • INAGAKI N, GONOI T, CLEMENT JP et al.: A family of sulfonylurea receptors determines the pharmacological properties of ATP-sensitive IQ- channels. Neuron (1996) 16:1011–1017.
  • LISS B, BRUINS R, ROEPER J: Alternativesulfonylurea receptor expression defines metabolic sensitivity of KATp channels in dopaminergic midbrain neurons. EMBO J. (1999) 18:833–846.
  • PIROTTE B, FONTAINE J, LEBRUN P: Recent advances in the chemistry of potassium channel openers. Curr. Med. Chem. (1995) 2:573–582.
  • MANNHOLD R: KATp channel openers: structure-activity relationships and therapeutic potential. Med. Res. Rev. (2004) 24:213–266.
  • LEBRUN P, ARKHAMMAR P, ANTOINE M-H, NGUYEN Q-A, BONDO HANSEN J, PIROTTE B: A potent diazoxide analogue activating ATP-sensitive IQ channels and inhibiting insulin release. Diabetologia (2000) 43:723–732.
  • 1-JANSEN JB, ARKHAIVIMAR PO, BODVARSDOE1IR TB, WAHL P: Inhibition of insulin secretion as a new drug target in the treatment of metabolic disorders. Curr. Med. Chem. (2004) 11:1595–1615.
  • MIURA T, MIKI T: ATP-sensitive IQ-channel openers: old drugs with new clinical benefits for the heart. Curr. Vasc. Pharmacol (2003) 1:251–258.
  • COGHLAN MJ, CARROLL WA, GOPALAKRISHNAN M: Recent developments in the biology and medicinal chemistry of potassium channel modulators: update from a decade of progress. J. Med. Chem. (2001) 44:1627–1653.
  • ASHCROFT FM, GRIBBLE FM: New windows on the mechanism of action of KATp channel openers. Trends PharmacoL Sci. (2000) 21:439–445.
  • GARLID KD, PAUCEK P, YAROV-YAROVOY Vet aL: Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive IQ channels. Possible mechanism of cardioprotection. Circ. Res. (1997) 81:1072–1082.
  • LEBRUN P, DEVREUX V, HERMANN M, HERCHUELZ k Similarities between the effects of pinacidil and diazoxide on ionic and secretory events in rat pancreatic islets. J. Pharmacol Exp. Ther. (1989) 250:1011–1018.
  • ANTOINE M-H, BERKENBOOM G, FANG Z-Y, FONTAINE J, HERCHUELZ A, LEBRUN P: Mechanical and ionic response of rat aorta to diazoxide. Eur. J. PharmacoL (1992) 216:299–306.
  • WANG H, ZHANG YL, TANG XC, FENG HS, GANG H: Targeting ischaemic stroke with a novel opener of ATP-sensitive potassium channels in the brain. MoL Pharmacol (2004) 66:1160–1168.
  • WANG H, LONG CL, ZHANG YL: A new ATP-sensitive potassium channel opener reduces blood pressure and reverses cardiovascular remodeling in experimental hypertension. J. Pharmacol Exp. Ther. (2005) 312:1326–1333.
  • NIELSEN FE, BODVARSDOTTIR TB, WORSAAE A et al.: 6-Chloro-3-alkylamino-4H-thieno [3,2-e] -1,2,4-thiadiazine 1,1-dioxide derivatives potently and selectively activate ATP-sensitive potassium channels of pancreatic 13-cells. J. Med. Chem. (2002) 45:4171–4187.
  • PIROTTE B, DE TULLIO P, LEBRUN P et al: 3-(Alkylamino)-4H-pyrido [4,3-e] - 1,2,4-thiadiazine 1,1-dioxides as powerful inhibitors of insulin release from rat pancreatic 13 cells: a new class of potassium channel openers?J. Med. Chem. (1993) 36:3211–3213.
  • DE TULLIO P, PIROTTE B, LEBRUN P et al: 3-and 4-substituted 4H-pyrido [4,3-e]-1,2,4-thiadiazine 1,1-dioxides as potassium channel openers: synthesis, pharmacological evaluation, and structure-activity relationships. J. Med. Chem. (1996) 39:937–948.
  • DE TULLIO P, BECKER B, BOVERIE S et al: Toward tissue-selective pancreatic B cells KATp channel openers belonging to 3-alkylamino-7-halo-4H-1,2,4-benzothiadiazine 1,1-dioxides. J. Med. Chem. (2003) 46:3342–3353.
  • PIROTTE B, ANTOINE M-H, DE TULLIO P et al: A pyridothiadiazine (BPDZ-44) as a new and potent activator of ATP-sensitive IQ channels. Biochem. Pharmacol (1994) 47:1381–1386.
  • COSGROVE KE, ANTOINE M-H, LEE AT et al: BPDZ-154 activates adenosine 5'-triphosphate-sensitive potassium channels: in vitro studies using rodent insulin-secreting cells and islets isolated from patients with hyperinsulinism. Clin. Endocrinol Metab. (2002) 87:4860–4868.
  • SEBILLE S, DE TULLIO P, BOVERIE S, ANTOINE M-H, LEBRUN P, PIROTTE B: Recent developments in the chemistry of potassium channel activators: the cromakalim analogs. Curr. Med. Chem. (2004) 11:1213–1222.
  • KOGA H, OHTA M, SATO H, ISHIZAWA T, NABATA H: Design of potent IQ- channel openers by pharmacophore model. Bioorg. Med. Chem. Lett. (1993) 3:625–631.
  • TAKA N, KOGA H, SATO H, ISHIZAWAT, TAKAHASHI T, IMAGAWA J: 6-Substituted 2,2-bis(fluoromethyp-benzopyran-4-carboxamide IQ- channel openers. Bioorg. Med. Chem. (2000) 8:1393–1405.
  • RAASMAJA A, TALO A, HAIKALA H,NISSINEN E, LINDEN IB, POHTO P: Biochemical properties of OR-1259, a positive inotropic and vasodilatory compound with an antiarrythmic effect. Adv. Exp. Med. Biol. (1992) 311:423.
  • KOPUSTINSKIENE DM, POLLESELLO P, SARIS NE: Levosimendan is a mitochondrial K(ATP) channel opener. Eur. j PharmacoL (2001) 428:311–314.

Websites

  • http://www.fcianews.com/ciailies/dpa/1_205/ news/18771-1.html Drug Pipeline Alert (5/11/2003).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.